Yolk sac tumour of ovary, YST,
endodermal sinus tumour
Clinical features
YST
usually
occurs in girls and young women.
Histopathology
YST may occur alone
on in combination with other components in a mixed germ cell tumour.
The histological
appearances vary, with glandular, reticular, solid, hepatoid,
poly-vesicular, parietal and papillary patterns.
Immunohistochemistry
|
Yolk sac tumour |
Ovarian carcinomas |
Pancytokeratin |
15/151 |
positive |
cytokeratin 7 |
0/16 (a few
cells (1-2%) stained in four cases)1 |
19/19
endometrioid1,
11/11 clear cell1,
positive9,10 |
EMA |
0/15 (12 cases
showed staining of less than 5% of cells)1,
0/14 (not
stated whether testicular or ovarian)11,
0/3 (not
stated whether testicular or ovarian)12 |
12/12
endometrioid1,
11/11 clear cell1 |
CD15 |
9/15 (staining
was less than 25% of cells)1,
2/75 |
15/19 endometrioid
(the extent of staining was variable)1,
11/11
(10 cases showed staining of more than 50% of cells)
clear cell1,
16/17 (9
ovarian and 8 vaginal clear cell carcinomas)5 |
WT1 |
0/161 |
2/18 endometrioid 1,
0/11 clear cell1 |
CD117 |
0/161 |
|
alpha-fetoprotein |
12/15
(staining is generally focal)1,
15/152, 6/75 |
0/19
endometrioid1,
0/11
clear cell1,
3/17 (9
ovarian and 8 vaginal clear cell carcinomas)5
|
|
|
|
Differential diagnosis
-
Glandular
pattern: endometrioid adenocarcinoma. Glandular YST usually
shows other patterns as well3.
Rarely,
YST and endometrioid carcinoma may occur together, usually in
postmenopausal women6,7,8.
-
Glandular,
papillary or hepatoid: clear cell carcinoma: patients with carcinoma
are usually older4.
AFP is positive in YST , but AFP has a low sensitivity and may
be positive in carcinomas. CK7 and EMA are positive in endometrioid
and clear cell carcinomas but not YST. CD15
is usually strongly positive in clear cell carcinomas and variably
positive in the endometrioid carcinomas but negative or weakly
positive in YST.
Prognosis
Hepatoid
yolk sac tumours of the ovary are highly aggressive.
References
1Ramalingam,
P., A. Malpica, et al. (2004). "The use of cytokeratin 7 and
EMA in differentiating ovarian yolk sac tumors from endometrioid and
clear cell carcinomas." Am J Surg Pathol 28(11): 1499-1505.
2Kurman,
R. J. and H. J. Norris (1976). "Endodermal sinus tumor of the
ovary: a clinical and pathologic analysis of 71 cases." Cancer
38(6): 2404-19.
3Clement,
P. B., R. H. Young, et al. (1987). "Endometrioid-like variant
of ovarian yolk sac tumor. A clinicopathological analysis of eight
cases." Am J Surg Pathol 11(10): 767-78.
4Ballotta,
M. R., E. Bianchini, et al. (1995). "Clear cell carcinoma
simulating the "endometrioid-like variant" of yolk sac
tumor." Pathologica 87(1): 87-90.
5Zirker,
T. A., E. G. Silva, et al. (1989). "Immunohistochemical
differentiation of clear-cell carcinoma of the female genital tract
and endodermal sinus tumor with the use of alpha-fetoprotein and
Leu-M1." Am J Clin Pathol 91(5): 511-4.
6Horiuchi,
A., R. Osada, et al. (1998). "Ovarian yolk sac tumor with
endometrioid carcinoma arising from endometriosis in a postmenopausal
woman, with special reference to expression of alpha-fetoprotein, sex
steroid receptors, and p53." Gynecol Oncol 70(2): 295-9.
7Kamoi,
S., Y. Ohaki, et al. (2002). "A case of ovarian endometrioid
adenocarcinoma with yolk sac tumor component in a postmenopausal
woman." Apmis 110(6): 508-14.
8Nogales,
F. F., C. Bergeron, et al. (1996). "Ovarian endometrioid tumors
with yolk sac tumor component, an unusual form of ovarian neoplasm.
Analysis of six cases." Am J Surg Pathol 20(9): 1056-66.
9Vang,
R., B. P. Whitaker, et al. (2001). "Immunohistochemical
analysis of clear cell carcinoma of the gynecologic tract." Int
J Gynecol Pathol 20(3): 252-9.
10Chu,
P., E. Wu, et al. (2000). "Cytokeratin 7 and cytokeratin 20
expression in epithelial neoplasms: a survey of 435 cases." Mod
Pathol 13(9): 962-72.
11Niehans,
G. A., J. C. Manivel, et al. (1988). "Immunohistochemistry of
germ cell and trophoblastic neoplasms." Cancer 62(6): 1113-23.
12Wick,
M. R., P. E. Swanson, et al. (1987). "Placental-like alkaline
phosphatase reactivity in human tumors: an immunohistochemical study
of 520 cases." Hum Pathol 18(9): 946-54.
This page last
revised 24.12.2004.